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Albicidin is a small molecule produced by the sugarcane pathogen Xanthomonas 
albilineans. Initially discovered as being involved in the occurrence of disease 
symptoms on sugarcane leaves, it was subsequent ly shown to possess a potent 
antibacterial activity. Albicidin exhibits antibacterial activity at the nanomolar ra nge 
against Escherichia coli and, to a lower extent, against a wide range of Gram-negative 
and Gram-positive human pathogenic bacteria . lt is a potent inhibitor of the 
supercoiling activity of the bacterial DNA gyrase by a mechanism that is different 
from those of other known DNA gyrase inhibitors (coumarins and quinolones, for 
instance). Although albicidin is a promising antibiotic for medical use because of its 
unique and potent antibacterial activity, the lack of structura l knowledge has 
impeded its considerat ion as a new lead compound by the pharmaceutical industry. 
Three decades of intense work have therefore been dedicated to both the study of 
the biosynthesis and the structure elucidation of albicidin, which is synthesized by a 
hybrid polyketide synthase/nonribosomal peptide synthetase (PKS/NRPS) system, 
and which is produced only in minute amounts by X. albilineans. In silica analyses of 
the complete albicidin biosynthesis gene cluster, in addition to analytical data, 
resulted in only partial structural data of the molecu le. In th is work, we report the 
development of a structure elucidation strategy using a combinat ion of HPLC 
purification with HPLC-ESI-orbitrap mass spectrometry and nuclear magnetic 
resonance (NMR) spectroscopy techniques along with studies of the biosynthesis 
pathway. Use of this protocol resulted in significant progress towards the structure 
elucidation of albicidin with the likely involvement of chorismate biosynthesis. The 
current status of albicidin structure elucidation and its potential for use as an 
antibiotic will be discussed. 
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